Cipla Australia Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
4 result(s) found, displaying 1 to 4
-
Prescription medicine decision summaryTGA decision: Ciptunec Ardalicip (adalimumab) is approved to treat arthritis.
-
Prescription medicine decision summaryTGA decision: Filpegla (pegfilgrastim) is approved for the treatment of cancer patients following chemotherapy.
-
Prescription medicine decision summaryTGA decision: Trastucip and Tuzucip (trastuzumab) are approved to treat breast cancer.
-
Prescription medicine decision summaryTGA decision: Bevacip/Bevaciptin (bevacizumab) is approved to treat various types of cancers.